MEDTRONIC PLC (2M6.DE) Stock Fundamental Analysis
FRA:2M6 • IE00BTN1Y115
83.93 EUR
-2.35 (-2.72%)
Last: Feb 11, 2026, 07:00 PM
Taking everything into account, 2M6 scores 5 out of 10 in our fundamental rating. 2M6 was compared to 63 industry peers in the Health Care Equipment & Supplies industry. 2M6 has only an average score on both its financial health and profitability. 2M6 has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- 2M6 had positive earnings in the past year.
- In the past year 2M6 had a positive cash flow from operations.
- Each year in the past 5 years 2M6 has been profitable.
- 2M6 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 5.22%, 2M6 is in the better half of the industry, outperforming 68.25% of the companies in the same industry.
- The Return On Equity of 2M6 (9.79%) is better than 65.08% of its industry peers.
- 2M6 has a Return On Invested Capital (6.63%) which is comparable to the rest of the industry.
- Measured over the past 3 years, the Average Return On Invested Capital for 2M6 is below the industry average of 9.98%.
- The 3 year average ROIC (6.35%) for 2M6 is below the current ROIC(6.63%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 9.79% | ||
| ROIC | 6.63% |
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
1.3 Margins
- 2M6 has a Profit Margin of 13.71%. This is in the better half of the industry: 2M6 outperforms 79.37% of its industry peers.
- 2M6's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 19.42%, 2M6 belongs to the top of the industry, outperforming 84.13% of the companies in the same industry.
- 2M6's Operating Margin has been stable in the last couple of years.
- Looking at the Gross Margin, with a value of 65.57%, 2M6 is in the better half of the industry, outperforming 69.84% of the companies in the same industry.
- In the last couple of years the Gross Margin of 2M6 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.42% | ||
| PM (TTM) | 13.71% | ||
| GM | 65.57% |
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 2M6 is destroying value.
- 2M6 has less shares outstanding than it did 1 year ago.
- 2M6 has less shares outstanding than it did 5 years ago.
- 2M6 has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 3.10 indicates that 2M6 is not in any danger for bankruptcy at the moment.
- 2M6 has a Altman-Z score of 3.10. This is in the better half of the industry: 2M6 outperforms 65.08% of its industry peers.
- 2M6 has a debt to FCF ratio of 5.59. This is a neutral value as 2M6 would need 5.59 years to pay back of all of its debts.
- 2M6's Debt to FCF ratio of 5.59 is in line compared to the rest of the industry. 2M6 outperforms 52.38% of its industry peers.
- 2M6 has a Debt/Equity ratio of 0.57. This is a neutral value indicating 2M6 is somewhat dependend on debt financing.
- 2M6's Debt to Equity ratio of 0.57 is on the low side compared to the rest of the industry. 2M6 is outperformed by 60.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 5.59 | ||
| Altman-Z | 3.1 |
ROIC/WACC0.98
WACC6.74%
2.3 Liquidity
- 2M6 has a Current Ratio of 2.42. This indicates that 2M6 is financially healthy and has no problem in meeting its short term obligations.
- 2M6's Current ratio of 2.42 is fine compared to the rest of the industry. 2M6 outperforms 74.60% of its industry peers.
- A Quick Ratio of 1.80 indicates that 2M6 should not have too much problems paying its short term obligations.
- With a decent Quick ratio value of 1.80, 2M6 is doing good in the industry, outperforming 79.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.42 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
- The Earnings Per Share has been growing slightly by 7.24% over the past year.
- 2M6 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.68% yearly.
- 2M6 shows a small growth in Revenue. In the last year, the Revenue has grown by 5.34%.
- The Revenue has been growing slightly by 3.01% on average over the past years.
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%
3.2 Future
- The Earnings Per Share is expected to grow by 6.08% on average over the next years.
- 2M6 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.80% yearly.
EPS Next Y3.73%
EPS Next 2Y6.06%
EPS Next 3Y6.38%
EPS Next 5Y6.08%
Revenue Next Year7.62%
Revenue Next 2Y6.75%
Revenue Next 3Y6.26%
Revenue Next 5Y5.8%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 17.74, the valuation of 2M6 can be described as rather expensive.
- 2M6's Price/Earnings ratio is rather cheap when compared to the industry. 2M6 is cheaper than 87.30% of the companies in the same industry.
- 2M6's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.18.
- The Price/Forward Earnings ratio is 16.14, which indicates a correct valuation of 2M6.
- 2M6's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 2M6 is cheaper than 76.19% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 28.01. 2M6 is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.74 | ||
| Fwd PE | 16.14 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 2M6 is valued a bit cheaper than the industry average as 61.90% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of 2M6 indicates a somewhat cheap valuation: 2M6 is cheaper than 73.02% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.6 | ||
| EV/EBITDA | 14.52 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of 2M6 may justify a higher PE ratio.
PEG (NY)4.76
PEG (5Y)4.82
EPS Next 2Y6.06%
EPS Next 3Y6.38%
5. Dividend
5.1 Amount
- 2M6 has a Yearly Dividend Yield of 2.76%.
- 2M6's Dividend Yield is rather good when compared to the industry average which is at 0.97. 2M6 pays more dividend than 87.30% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.80, 2M6 pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.76% |
5.2 History
- The dividend of 2M6 has a limited annual growth rate of 5.10%.
Dividend Growth(5Y)5.1%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
- 75.86% of the earnings are spent on dividend by 2M6. This is not a sustainable payout ratio.
- The dividend of 2M6 is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP75.86%
EPS Next 2Y6.06%
EPS Next 3Y6.38%
FRA:2M6 (2/11/2026, 7:00:00 PM)
83.93
-2.35 (-2.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-18 2025-11-18/bmo
Earnings (Next)02-17 2026-02-17/bmo
Inst Owners88.22%
Inst Owner ChangeN/A
Ins Owners0.28%
Ins Owner ChangeN/A
Market Cap107.60B
Revenue(TTM)34.76B
Net Income(TTM)4.76B
Analysts74.21
Price Target94.96 (13.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.76% |
Yearly Dividend2.35
Dividend Growth(5Y)5.1%
DP75.86%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.96%
Min EPS beat(2)1.49%
Max EPS beat(2)2.43%
EPS beat(4)4
Avg EPS beat(4)1.68%
Min EPS beat(4)1.21%
Max EPS beat(4)2.43%
EPS beat(8)6
Avg EPS beat(8)1.26%
EPS beat(12)9
Avg EPS beat(12)1.96%
EPS beat(16)10
Avg EPS beat(16)1.24%
Revenue beat(2)2
Avg Revenue beat(2)0.49%
Min Revenue beat(2)0.08%
Max Revenue beat(2)0.91%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)0.91%
Revenue beat(8)7
Avg Revenue beat(8)0.29%
Revenue beat(12)10
Avg Revenue beat(12)0.59%
Revenue beat(16)11
Avg Revenue beat(16)-0.1%
PT rev (1m)-1.09%
PT rev (3m)6.74%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)-0.94%
EPS NY rev (1m)0.08%
EPS NY rev (3m)0.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.74 | ||
| Fwd PE | 16.14 | ||
| P/S | 3.68 | ||
| P/FCF | 24.6 | ||
| P/OCF | 18 | ||
| P/B | 2.63 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.52 |
EPS(TTM)4.73
EY5.64%
EPS(NY)5.2
Fwd EY6.19%
FCF(TTM)3.41
FCFY4.07%
OCF(TTM)4.66
OCFY5.56%
SpS22.78
BVpS31.89
TBVpS-2.57
PEG (NY)4.76
PEG (5Y)4.82
Graham Number58.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.22% | ||
| ROE | 9.79% | ||
| ROCE | 8.29% | ||
| ROIC | 6.63% | ||
| ROICexc | 7.39% | ||
| ROICexgc | 26.33% | ||
| OM | 19.42% | ||
| PM (TTM) | 13.71% | ||
| GM | 65.57% | ||
| FCFM | 14.98% |
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score8
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 5.59 | ||
| Debt/EBITDA | 2.83 | ||
| Cap/Depr | 63.21% | ||
| Cap/Sales | 5.49% | ||
| Interest Coverage | 8.53 | ||
| Cash Conversion | 72.83% | ||
| Profit Quality | 109.28% | ||
| Current Ratio | 2.42 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 3.1 |
F-Score8
WACC6.74%
ROIC/WACC0.98
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
EPS Next Y3.73%
EPS Next 2Y6.06%
EPS Next 3Y6.38%
EPS Next 5Y6.08%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%
Revenue Next Year7.62%
Revenue Next 2Y6.75%
Revenue Next 3Y6.26%
Revenue Next 5Y5.8%
EBIT growth 1Y7.35%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year17.96%
EBIT Next 3Y11.21%
EBIT Next 5Y9.23%
FCF growth 1Y28.67%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y27.68%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%
MEDTRONIC PLC / 2M6.DE FAQ
What is the ChartMill fundamental rating of MEDTRONIC PLC (2M6.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 2M6.DE.
What is the valuation status for 2M6 stock?
ChartMill assigns a valuation rating of 5 / 10 to MEDTRONIC PLC (2M6.DE). This can be considered as Fairly Valued.
How profitable is MEDTRONIC PLC (2M6.DE) stock?
MEDTRONIC PLC (2M6.DE) has a profitability rating of 6 / 10.
What is the expected EPS growth for MEDTRONIC PLC (2M6.DE) stock?
The Earnings per Share (EPS) of MEDTRONIC PLC (2M6.DE) is expected to grow by 3.73% in the next year.
Is the dividend of MEDTRONIC PLC sustainable?
The dividend rating of MEDTRONIC PLC (2M6.DE) is 6 / 10 and the dividend payout ratio is 75.86%.